Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Crohn's disease

*

* Not a rare disease

Other Names for this Disease

  • Enteritis
  • Granulomatous colitis
  • Granulomatous enteritis
  • Ileitis
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Newline Maker

How might Crohn's disease be treated?

For information on the treatment of Crohn's disease, visit the following links:

National Digestive Diseases Information Clearinghouse: 
http://digestive.niddk.nih.gov/ddiseases/pubs/crohns_ez/index.htm#treat

Crohn's & Colitis Foundation of America: 
http://www.ccfa.org/what-are-crohns-and-colitis/what-is-crohns-disease/crohns-treatment-options.html

Complementary and Alternative Medicine (CAM) for Crohn's disease from the Crohn's & Colitis Foundation of America: 
http://www.ccfa.org/resources/complementary-alternative.html

Last updated: 11/15/2012


Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Crohn's disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Adalimumab
Trade Name
(Manufacturer Name)
Humira®
(AbbVie Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of Juvenile Idiopathic Arthritis. Reducing signs and symptoms and inducing and maintaining clinical remission in patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Infliximab
Trade Name
(Manufacturer Name)
Remicade®
(Centocor Ortho Biotech Inc.)
Indication
The FDA has approved this product to be used in this manner.
For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy
More Information about this product Drug Information Portal

Other Names for this Disease
  • Enteritis
  • Granulomatous colitis
  • Granulomatous enteritis
  • Ileitis
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.